First Time Loading...

Calithera Biosciences Inc
NASDAQ:CALA

Watchlist Manager
Calithera Biosciences Inc Logo
Calithera Biosciences Inc
NASDAQ:CALA
Watchlist
Price: 0.02 USD Market Closed
Updated: May 10, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

28.7m
-23%
Assets
Growth Rates:
1 Year
-56%
3 Years
-83%
5 Years
-85%
7 Years
-62%
10 Years
-
8.3m
-22%
Liabilities
Growth Rates:
1 Year
-47%
3 Years
-68%
5 Years
-80%
7 Years
+108%
10 Years
-
20.4m
-23%
Equity
Growth Rates:
1 Year
-58%
3 Years
-86%
5 Years
-86%
7 Years
-72%
10 Years
-

Balance Sheet Decomposition
Calithera Biosciences Inc

28.7m
Assets
8.3m
Liabilities
28.7m
Assets
8.3m
Liabilities
Current Assets 26.6m
Cash & Short-Term Investments 25.5m
Other Current Assets 1.1m
Non-Current Assets 2.1m
PP&E 1.8m
Other Non-Current Assets 300k
Current Liabilities 7.4m
Accounts Payable 700k
Accrued Liabilities 6.7m
Non-Current Liabilities 900k
Other Non-Current Liabilities 900k

Balance Sheet
Calithera Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
34
102
6
11
49
51
60
107
60
26
Cash Equivalents
34
102
6
11
49
51
60
107
60
26
Short-Term Investments
0
0
64
41
115
85
97
8
0
0
Total Receivables
0
0
0
0
1
2
1
2
0
0
Accounts Receivables
0
0
0
0
1
2
1
2
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
2
3
2
3
2
2
2
2
1
Total Current Assets
34
104
73
54
168
140
160
119
62
27
PP&E Net
1
1
1
1
2
2
8
6
3
2
PP&E Gross
1
1
0
1
2
2
8
6
3
2
Accumulated Depreciation
1
1
0
2
2
3
3
3
3
4
Long-Term Investments
0
0
2
0
22
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
1
1
1
0
0
0
Total Assets
35
N/A
105
+201%
76
-28%
55
-28%
193
+251%
143
-26%
169
+18%
126
-26%
65
-48%
29
-56%
Liabilities
Accounts Payable
0
1
1
0
1
1
2
2
4
1
Accrued Liabilities
1
3
3
4
9
14
18
16
10
7
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
29
0
0
0
0
0
Total Current Liabilities
1
4
4
5
39
15
20
18
14
7
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
3
1
7
5
2
1
Total Liabilities
1
N/A
4
+214%
4
-9%
5
+23%
42
+759%
16
-62%
26
+64%
23
-12%
16
-32%
8
-47%
Equity
Common Stock
54
0
0
0
0
0
0
0
41
22
Retained Earnings
30
52
85
123
150
196
286
376
491
513
Additional Paid In Capital
9
152
156
172
301
323
429
479
500
511
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
34
N/A
100
+200%
72
-28%
50
-31%
150
+201%
127
-16%
142
+12%
102
-28%
49
-52%
20
-58%
Total Liabilities & Equity
35
N/A
105
+201%
76
-28%
55
-28%
193
+251%
143
-26%
169
+18%
126
-26%
65
-48%
29
-56%
Shares Outstanding
Common Shares Outstanding
1
1
1
1
2
2
3
4
4
5
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
1

See Also

Summary
CALA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CALA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CALA stock valuation using valuation multiples.
Wall Street Estimates
CALA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CALA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.